Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Apellis Pharmaceuticals (APLS)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis ...
Vertex Pharmaceuticals price target raised to $420 from $408 at RBC Capital
RBC Capital raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $420 from $408 and keeps a Sector Perform rating on the shares.
Fierce Biotech3d
Vertex abandons islet cell-device combo after failing to improve diabetes biomarker
Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...
thehealthy15d
Here’s How I Knew I Had Glaucoma: A Patient’s Story After Putting Off Eye Check-ups
Over 4,000,000 Americans are living with glaucoma, many without knowing. A woman in her fifties details her subtle symptoms, and how her sight was saved. The Cleveland Clinic explains that glaucoma, ...
Northern Territory News19d
An out of form Anglesea to play Barwon Heads in an A1 semi-final
Don't miss out on the headlines from News. Followed categories will be added to My News. The Seagulls downed Anglesea in the A1 grand final last March in its first season post-promotion, as the ...
The Cairns Post19d
An out of form Anglesea to play Barwon Heads in an A1 semi-final
It will be a grand final rematch in the BPCA’s top tier as Wallington and Collendina approach A2 semi-finals in magnificent batting form after historic deeds. The Seagulls downed Anglesea in the ...
The Motley Fool23d
Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...